A groundbreaking study from Penn Medicine reveals that psilocybin may effectively alleviate chronic pain and improve mental health by targeting specific brain circuits. This research opens new avenues for non-addictive therapies.
A groundbreaking clinical trial reveals that low-dose radiation therapy may provide significant pain relief for individuals suffering from knee osteoarthritis, offering a safer alternative to traditional pain management methods.
This week, President Trump's advice to pregnant women about Tylenol and autism has ignited a firestorm of controversy. Experts are pushing back, urging families not to panic over misleading claims linking pain relief to autism. Discover the facts behind this heated debate.
After years of debilitating pain from rheumatoid arthritis, Lynn Milam found relief with an experimental device that stimulates the vagus nerve. This FDA-approved implant could transform the lives of many suffering from autoimmune diseases.
In a controversial announcement, the Trump administration warns that Tylenol use during pregnancy may be linked to autism. The FDA recommends limiting its use, despite ongoing debates among medical experts and manufacturers.
In a recent announcement, Trump suggests a potential link between Tylenol use during pregnancy and autism. While some studies hint at this correlation, experts caution against jumping to conclusions.
After years of debilitating pain, Edward Mowery found hope through a cutting-edge pain management technique that could change lives. Discover how this innovative approach is transforming chronic pain treatment without opioids.
A new scientific review suggests a possible link between Tylenol use during pregnancy and autism, reigniting debate over the painkiller's safety and its implications for fetal brain development. Could this change how we view pain relief during pregnancy?
Dr. Sanjay Gupta shares his personal experience with pain and discusses innovative techniques for pain management in his new book. Discover how the brain processes pain and the potential of new treatments!
New research suggests that acetaminophen, a common pain reliever, may increase risk-taking behavior by reducing negative emotions. With 25% of Americans using it weekly, the implications could be significant!
